Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Increase to 0.5 mg weekly for the next 4 weeks
It is FDA-approved for chronic weight management in adults with obesity, or overweight with at least one weight-related comorbid condition, and to reduce the risk of major cardiovascular events (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke) in adults with established cardiovascular disease and obesity or overweight
GLP-1 receptors are expressed in brain regions involved in reward processing and food motivation, including the nucleus accumbens and ventral tegmental area
Most patients experience steady weight loss over several months, with optimal results occurring after consistent treatment and lifestyle adjustments
GLP-1 list prices are rising, but the net prices have been quietly falling for years
US$ 29.78
US$ 21.06
US$ 22.32
US$ 26.41
US$ 25.75
US$ 23.45
US$ 25.62
US$ 20.23
US$ 21.83
